Conversion Disorder Clinical Trial
Official title:
Randomised Feasibility Study of a Physiotherapy Programme for Patients With Functional Motor Symptoms (FMS).
The aim of this study is to develop and assess the feasibility of a physiotherapy intervention for people with functional motor symptoms (also known as psychogenic neurological symptoms and conversion disorder). Participants will be randomised to receive the intervention or a "treatment as usual" control.
Participants will be recruited from outpatient neurology clinics at Queen Square. Those who
consent to take part will complete baseline outcome measures (Time 1) before being
randomised to either a Treatment as Usual control group or the Intervention group.
Treatment as Usual group -
1. Participants will be directed to online patient information resources
(www.neurosymptoms.org)
2. Participants will be placed on the waiting list to be assessed for the inpatient
treatment programme for functional symptoms at The National Hospital for Neurology and
Neurosurgery. The waitlist is currently greater than 12 months.
3. A referral is made to local community therapy services (which may include
physiotherapy, occupational therapy and psychological therapy). If the participant has
had contact from their community therapy services in the previous 12 months, a letter
summarising the participant's diagnosis and physiotherapy needs will be sent.
4. Participants will be asked to return at 4 weeks to complete outcome measures for a
second time (Time 2)
A referral to community therapy for such patients is usual practice in the UK, although the
form in which the community therapy is provided tends to be inconsistent across the UK. In
most cases it will entail between 1 and 8 outpatient or domiciliary physiotherapy
appointments. Some communities will have access to Occupational Therapy, which may entail
supported practice and advice to increase independence with functional tasks and the
provision of equipment. The provision of community therapy to participants will be monitored
through the CSRI.
Intervention Group -
For participants allocated to the intervention group, a 5 day admission on the Day Hospital
at the National Hospital for Neurology and Neurosurgery is arranged. The physiotherapy
intervention will take place in the physiotherapy department. Participants will be admitted
individually (and not in groups). Outside of physiotherapy times participants are encouraged
to rest in the day hospital and complete a workbook. A single independent physiotherapist
will be trained to deliver the intervention.
The participant (+/- family member) will attend an initial meeting with the consultant
neurologist and the treating physiotherapist. The neurologist will perform a brief
neurological assessment and confirm the diagnosis.
1. The diagnosis will be explained again to the patient, using the word "functional" to
describe the diagnosis.
2. Physical signs of FMS will be demonstrated to the patient. This includes
distractibility, Hoover's sign and entrainment.
3. The treatment programme will be explained to the patient, linking resolution of
symptoms with treatment rationale.
4. The participant will attend 8-9 physiotherapy sessions over the 5 days. The
intervention is a combination of education on functional motor symptoms, movement
retraining and development of a self management plan.
5. After the final physiotherapy session, the participant will complete the outcome
measures (Time 2) and a feedback form.
Both groups will be followed up at 6 months after recruitment to the study (Time 3). An
independent assessor will administer the outcome measures.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00971360 -
Cytokine Levels in Conversion Disorder
|
N/A | |
Completed |
NCT00835627 -
Treatment Trial for Psychogenic Nonepileptic Seizures
|
Phase 4 | |
Active, not recruiting |
NCT01422278 -
Rehabilitation of Conversion Gait Disorder
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03441867 -
Neuroimaging Biomarker for Seizures
|
N/A | |
Completed |
NCT03398070 -
Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders
|
||
Completed |
NCT02102906 -
TMS and Attentional Bias in Functional Motor Disorder
|
N/A | |
Completed |
NCT02325544 -
Comparing Different Treatments in Reducing Dissociative Seizure Occurrence
|
N/A | |
Terminated |
NCT02764476 -
Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder
|
N/A | |
Recruiting |
NCT05323344 -
Metacognitive Therapy and Neuro-physiotherapy as a Treatment for Functional Movement Disorders
|
N/A | |
Recruiting |
NCT04097184 -
Efficacy of Dorso-lateral Prefrontal Cortex Stimulation by tDCS in Motor Conversion Disorder Patients
|
N/A | |
Completed |
NCT05219006 -
Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures
|
N/A | |
Completed |
NCT02329626 -
Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder
|
||
Recruiting |
NCT05943652 -
Observational Study on "Functional Overlay" in Patients With Movement Disorders
|
||
Completed |
NCT00159965 -
Treatments for Psychogenic Nonepileptic Seizures (NES)
|
Phase 4 | |
Completed |
NCT05305014 -
Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder
|